The role of actin polymerization in tumor metastasis

肌动蛋白聚合在肿瘤转移中的作用

基本信息

  • 批准号:
    6944259
  • 负责人:
  • 金额:
    $ 41.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2007-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by applicant) The long-term goal of this application is to understand the molecular mechanism ot tumor metastasis. Prior works have established that amplification of the chromosome 11q13, which occurs frequently in breast cancer, head and neck squamous carcinomas and bladder cancer, results in overexpression of cortactin or EMS 1, a prominent substrate of protein tyrosine kinase Src with potential to associate with actin filaments. Patients with gene amplification of cortactin tend to have poor prognosis and increased possibility of relapse. However, the mechanism by which cortactin contributes to tumor progression is still unknown. There has been accumulated evidence that cortactin is implicated in the modulation of cell cytoskeletal changes associated with cell motility and cell shape changes. Our recent study further demonstrated that cortactin plays an important role in actin polymerization via interaction with Arp2/3 complex, a key protein machinery to initiate actin polymerization within cells. Furthermore, cortactin modulates the activity of Arp2/3 complex for actin nucleation and actin branching, two important steps in the formation of cell leading edge structures. We also found that overexpression of wild-type cortactin can enhance cell motility in vitro and facilitate tumor metastasis in vivo, whereas overexpression of cortactin mutants either in tyrosine phosphorylation or Arp2/3 binding can impair cell migration and bone metastasis. Based on these observations, we hypothesize that actin polymerization mediated by Arp2/3 complex and cortactin plays an important role in tumor metastasis. To test this hypothesis, we propose to delineate the detailed interactions among Arp2/3 complex and cortactin, explore the regulation of cortactin/Arp2/3 complex by Src, PIP2 and other cellular factors, and to test the hypothesis whether or not inhibition of actin polymerization by disruption of these interactions would be effectively able to compromise metastasis in vivo. Thus, the specific aims for this application include: (1) Characterization of the mechanism by which cortactin activates the activity of Arp2/3 complex for actin nucleation and branching. We will characterize the structural basis for the interactions between cortactin and Arp2/3 complex, examine the mechanism by which cortactin enhances actin nucleation and promotes and stabilizes actin branching. (2) Study of the regulation of cortactin/Arp2/3-mediated actin nucleation and branching. We will assess the effect of Src and PIP2 on the actin nucleation and branching mediated by cortactin/Arp2/3 complex in vitro, and search for other cellular factor(s) through which Src, PIP2, Cdc42 and Rac may regulate the function of cortactin/Arp2/3 complex. (3) Analysis of the effects of the mutants derived from Arp2/3 and cortactin on tumor metastasis. We will introduce using retrovirus functional peptides derived from Arp2/3 and cortactin that can disrupt or enhance actin polymerization into MDA-MB-23 1 tumor cells. Next, we will evaluate the motility and metastatic potentials of these cells both in vitro and in vivo.
描述:(由申请人提供)本申请的长期目标是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven ZHAN其他文献

Steven ZHAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven ZHAN', 18)}}的其他基金

The Role of MIM in growth factor signaling and cell motility
MIM 在生长因子信号传导和细胞运动中的作用
  • 批准号:
    7674782
  • 财政年份:
    2006
  • 资助金额:
    $ 41.72万
  • 项目类别:
Role of Missing Metastasis Gene in tumor progression
缺失转移基因在肿瘤进展中的作用
  • 批准号:
    8634726
  • 财政年份:
    2006
  • 资助金额:
    $ 41.72万
  • 项目类别:
The Role of MIM in growth factor signaling and cell motility
MIM 在生长因子信号传导和细胞运动中的作用
  • 批准号:
    7263948
  • 财政年份:
    2006
  • 资助金额:
    $ 41.72万
  • 项目类别:
Role of Missing Metastasis Gene in tumor progression
缺失转移基因在肿瘤进展中的作用
  • 批准号:
    8297358
  • 财政年份:
    2006
  • 资助金额:
    $ 41.72万
  • 项目类别:
The Role of MIM in growth factor signaling and cell motility
MIM 在生长因子信号传导和细胞运动中的作用
  • 批准号:
    7899766
  • 财政年份:
    2006
  • 资助金额:
    $ 41.72万
  • 项目类别:
Role of Missing Metastasis Gene in Tumor Progression
缺失转移基因在肿瘤进展中的作用
  • 批准号:
    8959131
  • 财政年份:
    2006
  • 资助金额:
    $ 41.72万
  • 项目类别:
The Role of MIM in growth factor signaling and cell motility
MIM 在生长因子信号传导和细胞运动中的作用
  • 批准号:
    7144292
  • 财政年份:
    2006
  • 资助金额:
    $ 41.72万
  • 项目类别:
Role of Missing Metastasis Gene in tumor progression
缺失转移基因在肿瘤进展中的作用
  • 批准号:
    8454445
  • 财政年份:
    2006
  • 资助金额:
    $ 41.72万
  • 项目类别:
The Role of MIM in growth factor signaling and cell motility
MIM 在生长因子信号传导和细胞运动中的作用
  • 批准号:
    7483189
  • 财政年份:
    2006
  • 资助金额:
    $ 41.72万
  • 项目类别:
The role of actin polymerization in tumor metastasis
肌动蛋白聚合在肿瘤转移中的作用
  • 批准号:
    6777051
  • 财政年份:
    2002
  • 资助金额:
    $ 41.72万
  • 项目类别:

相似海外基金

A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
  • 批准号:
    22KJ2613
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
  • 批准号:
    10552100
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
  • 批准号:
    10520211
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
Thick and Thin Filament Dysfunction in Obese Heart Failure with Preserved Ejection Fraction
射血分数保留的肥胖性心力衰竭的粗细丝功能障碍
  • 批准号:
    10678204
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
  • 批准号:
    10677169
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
Cytoskeleton-mediated regulation of insulin secretion hot spots in pancreatic beta cells
细胞骨架介导的胰腺β细胞胰岛素分泌热点的调节
  • 批准号:
    10679903
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
Decoding dynamic interplay between signaling and membranes in chemotaxis bymolecular actuators
通过分子致动器解码趋化中信号传导和膜之间的动态相互作用
  • 批准号:
    10846921
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
Modulators of cardiomyocyte structure to promote functional recovery during cardiac regeneration and repair
心肌细胞结构调节剂促进心脏再生和修复过程中的功能恢复
  • 批准号:
    10751640
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
  • 批准号:
    10603436
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
用他汀类药物靶向转录共激活剂 YAP 和 TAZ,以防止 HLA 供体特异性抗体导致实体器官移植排斥
  • 批准号:
    10734277
  • 财政年份:
    2023
  • 资助金额:
    $ 41.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了